Cite
HARVARD Citation
Yarur, A. et al. (n.d.). DOP048 Vedolizumab levels during induction are associated with long-term clinical and endoscopic remission in patients with inflammatory bowel disease. Journal of Crohn's and colitis. pp. S064-S065. [Online].